跳至主要内容
临床试验/NCT04830241
NCT04830241Unknown不适用

Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant-Analysis of Two Pharmacovigilance Databases

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2021年3月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
10,000
试验地点
1
主要终点
neonatal hypotonia

研究概览

简要总结

To better characterize the neonatal hypotonia associated with in utero exposure to antidepressants, so far limited to clinical cases, we will perform an observational retrospective pharmacovigilance study, using two databases. First, disproportionality analysis in Vigibase®, the World Health Organization global database, will be perform between antidepressant drugs and neonatal hypotonia . Second, narratives from the French National Pharmacovigilance Database will be extracted.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
1 Day 至 30 Days(Child)
性别
All
接受健康志愿者

入选标准

  • neonatal hypotonia newborns cases associated with in utero exposure to antidepressant drugs

排除标准

  • Reports with maternal suicide, congenital malformation and hypotonia occurring only during breastfeeding

结局指标

主要结局

neonatal hypotonia

时间窗: Case reported in the World Health Organization (WHO) pharmacovigilance database to April 1st 2021

Identification and extractions of cases of neonatal hypotonia newborns following in utero exposure to antidepressant drugs

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验